Keeping tabs on SARS-CoV-2

In the ENDVOC project we will study
variants of concern across the world

Supporting the global response to COVID-19 and future pandemics

We will evaluate the impact of different variants in
diagnostics, treatment, and public health strategies

By investigating the circulation and impact of current and emerging
variants of concern (VOC), we aim to evaluate and
support effective pandemic responses. To do so, we will use data from
well-established patient and population cohorts across the world.

” Detecting emerging Covid-19 variants of concern, and understanding their
implications on diagnostics, vaccination strategies and treatment options
is key to guiding our response to the virus”
Ibrahim Abubakar, principal researcher of the project based at UCL

ENDVOC in numbers

Our project at a glance








Key research

Where we work

Our alliance covers a variety of countries worldwide


  • Partners
  • Cohorts

What’s new

Keep track of our activities and results

Our partners in Pakistan: a cohort focused on immunocompromised patients

COVID-19 screening at the Pakistan Institute of Medical Science By collecting and analysing data from a variety of well-established cohorts across the world, END-VOC hopes to rapidly identify and characterize emerging SARS-CoV-2 variants. In this interview, our partners in Pakistan (the DOPASI Foundation) explain the work they have been doing on COVID-19 and why their cohort is quite unique. Can you briefly explain who you are [...]

May 24, 2023|

ENDVOC Scientific Symposium, June 6, 2023 (online)

Scientific Symposium: “COVID-19 variants and the next pandemic” What have we learned from the COVID-19 pandemic and where do we go from here? How do we anticipate the next pandemic? In the context of its first annual meeting, ENDVOC is organising a Scientific Symposium on June 6, 2023 (13h30 to 20h CEST)  and inviting the scientific and broader community to connect online. To register to the event, please [...]

May 2, 2023|

Long COVID: 3 challenges and a way forward

This post was written by two ENDVOC team members: Robert Aldridge, Professor of Public Health & Data Science at UCL,  and his colleague Sarah Beale. Robert Aldridge leads ENDVOC's WP7, which focuses on the impact of viral variants on long COVID.  He co-led the Virus Watch study, in which Sarah Beale also participated. We have made huge strides in understanding, preventing, and treating coronavirus disease 2019 (COVID-19) since [...]

April 3, 2023|

The ENDVOC team

Our multidisciplinary consortium brings
together major research institutions

Go to Top